Mechanism and specificity of the human paracaspase MALT1
Open Access
- 14 March 2012
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 443 (1) , 287-295
Abstract
The paracaspase domain of MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) is a component of a gene translocation fused to the N-terminal domains of the cellular inhibitor of apoptosis protein 2. The paracaspase itself, commonly known as MALT1, participates in the NF-κB (nuclear factor κB) pathway, probably by driving survival signals downstream of the B-cell antigen receptor through MALT1 proteolytic activity. We have developed methods for the expression and purification of recombinant full-length MALT1 and its constituent catalytic domain alone. Both are activated by dimerization without cleavage, with a similar dimerization barrier to the distantly related cousins, the apical caspases. By using positional-scanning peptidyl substrate libraries we demonstrate that the activity and specificity of full-length MALT1 is recapitulated by the catalytic domain alone, showing a stringent requirement for cleaving after arginine, and with striking peptide length constraints for efficient hydrolysis. Rates of cleavage (kcat/Km values) of optimal peptidyl substrates are in the same order (103–104 M−1·s−1) as for a putative target protein CYLD. Thus MALT1 has many similarities to caspase 8, even cleaving the putative target protein CYLD with comparable efficiencies, but with diametrically opposite primary substrate specificity.Keywords
This publication has 41 references indexed in Scilit:
- Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase regionProceedings of the National Academy of Sciences, 2011
- Caspase 8 inhibits programmed necrosis by processing CYLDNature Cell Biology, 2011
- Oligomeric Structure of the MALT1 Tandem Ig-Like DomainsPLOS ONE, 2011
- Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell linesProceedings of the National Academy of Sciences, 2011
- T‐cell receptor‐induced JNK activation requires proteolytic inactivation of CYLD by MALT1The EMBO Journal, 2011
- Cleavage of NIK by the API2-MALT1 Fusion Oncoprotein Leads to Noncanonical NF-κB ActivationScience, 2011
- Emerging principles in protease-based drug discoveryNature Reviews Drug Discovery, 2010
- MEROPS: the peptidase databaseNucleic Acids Research, 2007
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992
- On the size of the active site in proteases. I. PapainBiochemical and Biophysical Research Communications, 1967